Skip to main content

SZ 145 (Guanfacine Hydrochloride Extended-Release 4 mg)

Pill with imprint SZ 145 is White, Elliptical/Oval and has been identified as Guanfacine Hydrochloride Extended-Release 4 mg. It is supplied by Sandoz Inc.

Guanfacine is used in the treatment of adhd; high blood pressure and belongs to the drug class antiadrenergic agents, centrally acting. There is no proven risk in humans during pregnancy. Guanfacine 4 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for SZ 145

Guanfacine Hydrochloride Extended-Release

SZ 145
4 mg
Prescription only
Drug Class
Antiadrenergic agents, centrally acting
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Sandoz Inc.
National Drug Code (NDC)
00781-5457 (Discontinued)
Inactive Ingredients
silicon dioxide, crospovidone, fumaric acid, glyceryl dibehenate, hypromellose 2208 (100 mPa.s), lactose monohydrate, methacrylic acid - ethyl acrylate copolymer (1:1) type a, microcrystalline cellulose, povidone

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.